Acetophenone-Azine Allergy From Hockey Shin Pads in One Player
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact paper measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | One boy in the United Kingdom with dermatitis localized to the shins after hockey shin-pad exposure. |
| Design | Case report with patch testing of pad pieces and acetophenone azine (AA), plus high-performance liquid chromatography of pad samples. |
| Comparator | Patch-test reactions to the patient's own pad pieces and serial AA concentrations; no unexposed control group. |
| Timepoint | Clinical presentation and patch-test readings; AA reactions were reported down to 0.001% in acetone. |
| Key result | Strong positive patch-test reactions occurred to pad pieces and AA down to 0.001%; the authors identified AA in the shin pads and proposed 0.1% AA in acetone for diagnostic testing. |
| Funding/conflict context | Funding and author conflicts were not stated in the PubMed abstract. |
What was actually measured?
Strong positive patch-test reactions occurred to pad pieces and AA down to 0.001%; the authors identified AA in the shin pads and proposed 0.1% AA in acetone for diagnostic testing.
The investigation triangulated clinical distribution, patient-specific patch testing and chemical analysis, but it remains a single diagnostic case and does not estimate population risk.
The denominator defines the claim. A diagnostic case, a patch-test reaction, a material analysis and a population rate answer different questions. None should be silently converted into another.
What the result does not prove
One referred case cannot establish frequency, predict reactions in other players or prove that every shin-pad dermatitis has the same cause.
Temporal or anatomic alignment can strengthen an exposure hypothesis, but it does not automatically prove individual causation. Referral patterns, prior sensitization, friction, sweat, occlusion, cleaning products, adhesives, metals, rubber additives and equipment age may all shape the finding.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the paper’s conclusions, this interpretation or any product.
Keep the condition categories separate
Dryness, friction injury, irritant dermatitis, allergic contact dermatitis, infection and swelling are not interchangeable. Patch testing evaluates delayed contact allergy; it does not diagnose every rash or replace clinician judgment.
Rapid facial or throat swelling, breathing difficulty, spreading redness, drainage, fever, severe pain, widespread blistering or loss of function requires prompt medical assessment. Do not deliberately re-expose yourself to suspected equipment or chemicals.
Activity and exposure details worth documenting
- Exact equipment, surface, material, adhesive, cleaner, glove, shoe, strap or instrument touching the area.
- Location and shape of the skin change relative to the contact site.
- Time from exposure to symptoms, and what changed during rest or avoidance.
- Sweat, friction, pressure, wetness, occlusion, ultraviolet exposure and cleaning routines.
- Manufacturer material disclosures, workplace safety data and clinician-directed testing—not self-testing.
Prevention comes before cosmetic care
Prevention must match the hazard: fit and friction control, material substitution, protective equipment, engineering controls, occupational-health review and clinician-guided allergen avoidance. Never apply workplace or sports chemicals directly to skin to “test” them.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 30829808
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: contact dermatitis
- American Academy of Dermatology: dry-skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This paper did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, allergy, infection, blisters or swelling; relieves pain or itch; neutralizes an allergen; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Measured UV Exposure in 168 Outdoor-Pool Lifeguards
- Sun-Protection Reports From 81 Junior Tennis Players
- Contact Dermatitis From One Worker’s Computer Mouse
- Skin Findings in 97 Orchestra Musicians and 20 Singers
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation, product-safety determination or occupational clearance.